The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,028.00
Bid: 12,012.00
Ask: 12,016.00
Change: -268.00 (-2.18%)
Spread: 4.00 (0.033%)
Open: 12,226.00
High: 12,266.00
Low: 11,988.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

Mon, 29th Apr 2024 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

Deutsche Bank raises Experian target to 3,500 (2,918) pence - 'hold'

----------

Deutsche Bank starts JD Sports with 'hold' - price target 115 pence

----------

Barclays cuts JD Sports to 'equal weight' - price target 140 pence

----------

Deutsche Bank starts Frasers with 'buy' - price target 1,000 pence

----------

RBC raises AB Foods price target to 2,900 (2,700) pence - 'outperform'

----------

Barclays raises Unilever price target to 5,000 (4,600) pence - 'overweight'

----------

DZ Bank raises AstraZeneca price target to 12,200 (10,400) pence - 'hold'

----------

Barclays raises Beazley price target to 910 (790) pence - 'overweight'

----------

UBS raises NatWest price target to 340 (315) pence - 'buy'

----------

Berenberg raises NatWest price target to 350 (325) pence - 'buy'

----------

JPMorgan raises NatWest price target to 350 (330) pence - 'overweight'

----------

RBC raises NatWest price target to 355 (340) pence - 'sector perform'

----------

Bank of America raises NatWest price target to 335 (320) pence - 'buy'

----------

RBC raises Barclays price target to 260 (255) pence - 'outperform'

----------

Bank of America cuts London Stock Exchange price target to 10,700 (11,100) pence - 'buy'

----------

FTSE 250

----------

Deutsche Bank starts Watches of Switzerland with 'hold' - price target 370 pence

----------

Deutsche Bank starts Moonpig with 'hold' - price target 180 pence

----------

Deutsche Bank starts Dr Martens with 'hold' - price target 65 pence

----------

Deutsche Bank starts Currys with 'hold' - price target 58 pence

----------

Deutsche Bank starts AO World with 'buy' - price target 120 pence

----------

Barclays raises Lancashire price target to 790 (770) pence - 'equal weight'

----------

Barclays raises Hiscox price target to 1,340 (1,190) pence - 'equal weight'

----------

RBC cuts WH Smith price target to 1,500 (1,600) pence - 'outperform'

----------

HSBC reinitiates Serco with 'buy' - price target 210 pence

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Deutsche Bank starts Motorpoint with 'buy' - price target 170 pence

----------

Deutsche Bank starts boohoo with 'sell' - price target 27 pence

----------

Deutsche Bank starts Mothercare with 'buy' - price target 12 pence

----------

Goldman Sachs raises Just Eat Takeaway price target to 16 (15.80) EUR - 'neutral'

----------

Peel Hunt raises Sabre Insurance to 'buy' - price target 210 pence

----------

Jefferies cuts AB Dynamics price target to 1,490 (1,500) pence - 'underperform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All rights reserved.

More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.